Rapid initiation of quetiapine well tolerated as compared with the conventional initiation regimen in patients with schizophrenia or schizoaffective disorders
A 2-week, randomized, parallel-group open trial was designed to evaluate the safety and tolerability of a rapid initiation regimen with a higher dose of quetiapine (up to 800 mg/d by Day 4) than that used in the conventional initiation regimen of quetiapine (up to 400 mg/d by Day 5) in patients with...
Main Authors: | Cheng-Cheng Hsiao, Kun-Po Chen, Chang-Jer Tsai, Liang-Jen Wang, Chih-Ken Chen, Shih-Ku Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-11-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1607551X11001355 |
Similar Items
-
Comparison of tolerability between quetiapine and haloperidol in schizophrenia
by: Naba Raj Koirala, et al.
Published: (2012-12-01) -
Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
by: Maneeton B, et al.
Published: (2017-04-01) -
Efficacy and tolerability of clozapine versus quetiapine in treatment-resistant schizophrenia
by: Mitesh Kumar, et al.
Published: (2017-01-01) -
Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials
by: Maneeton N, et al.
Published: (2016-01-01) -
Quetiapine-induced priapism
by: Murat Eren Ozen, et al.
Published: (2018-06-01)